1. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet. 2003; 362:53–61.
Article
2. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005; 353:1261–1273.
Article
3. Chon CY, Park JY. Primary biliary cirrhosis. Korean J Hepatol. 2006; 12:364–372.
4. Nishio A, Keeffe EB, Ishibashi H, Gershwin EM. Diagnosis and treatment of primary biliary cirrhosis. Med Sci Monit. 2000; 6:181–193.
5. Leuschner U. Primary biliary cirrhosis-presentation and diagnosis. Clin Liver Dis. 2003; 7:741–758.
Article
6. Kim KH, Han JY, Kim JM, Jang JS, Lee SW, Lee JH, et al. Determination of anti-mitochondrial antibody with M2 antigens. Korean J Lab Med. 2005; 25:104–110.
7. Berg PA, Klein R, Lindenborn-Fotinos J. Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol. 1986; 2:123–131.
Article
8. Hohenester S, Oude-Elferink RP, Beuers U. Primary biliarcirrhosis. Semin Immunopathol. 2009; 31:283–307.
9. Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, MacCariello S, et al. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol. 2004; 135:154–158.
Article
10. Miyakawa H, Tanaka A, Kikuchi E, Matusushita M, Kitazawa E, Kawaguchi N, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology. 2001; 34:243–248.
Article
11. Muratori P, Muratori L, Cassani F, Terlizzi P, Lenzi M, Rodrigo L, et al. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders. Clin Exp Immunol. 2002; 127:172–175.
Article
12. Invernizzi P, Podda M, Battezzati PM, Crosignani A, Zuin M, Hitchman E, et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol. 2001; 34:366–372.
Article
13. Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol. 2003; 98:431–437.
Article
14. Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, et al. Anti-gp210 and anticentromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2007; 45:118–127.
Article
15. Walker JG, Doniach D, Roitt IM, Sherlock S. Serological test in diagnosis of primary biliary cirrhosis. Lancet. 1965; 1:827–831.
16. Ishibashi H, Shimoda S, Gershwin ME. The immune response to mitochondrial autoantigens. Semin Liver Dis. 2005; 25:337–346.
Article
17. Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, et al. Autoreactivity to lipoate and conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology. 2003; 125:1705–1713.
Article
18. Zein CO, Angulo P, Lindor KD. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? Clin Gastroenterol Hepatol. 2003; 1:89–95.
Article
19. Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis. 2008; 12:261–276.
Article
20. Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003; 7:759–777.
Article
21. Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology. 1994; 106:193–199.
Article
22. Milkiewicz P, Buwaneswaran H, Coltescu C, Shums Z, Norman GL, Heathcote EJ. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. Clin Gastroenterol Hepatol. 2009; 7:1355–1360.
Article
23. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis. 2005; 25:298–310.
Article
25. Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, et al. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. J Hepatol. 2005; 42:386–392.
Article
26. Worman HJ. Nuclear envelope protein autoantigens in primary biliary cirrhosis. Hepatol Res. 2007; 37:S3. S406–S411.
Article